The latest funding rounds, like eMed ’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New funding rounds, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Industry Trends
See who's moving and how much in your market
No credit card required Weekly funding digest
eMed has raised $200 million in a Series A funding round led by AON Consulting, Inc. The financing will enhance eMed's AI platform and support employer healthcare solutions.
PRIVATEMar 26, 2026•3 months ago
Amount Raised
$200 Million
Round Type
series a
MiamiHealth Care
Investors
Linda YaccarinoTom RickettsR.J. MelmanJoe LonsdaleAntonio GraciasAra CohenJeff AroninTom BradyAon Consulting, Inc.
Description
Miami based eMed today announced it has raised $200 million in funding at a $2 billion plus valuation. The round included investors such as Tom Brady and Jeff Aronin, among others. This funding will advance eMed's agentic AI platform and support a new healthcare model for employers. eMed aims to change the landscape of GLP-1 medications as a workplace benefit.
Company Information
Company
eMed
Location
Miami, Florida, United States
About
eMed® is the world's first end-to-end GLP-1 care platform built on Empathetic AI™. From remote diagnostics and clinician-led prescriptions to adherence coaching and insights, eMed empowers employers to manage population health with accountability and compassion.
MiamiHealth Care